India's opportunity to leverage its services, experience-driven sectors as engines of growth: NSE CEO Ashish Chauhan
Participants examined the impact of escalating tariff and non-tariff barriers on its strategically vital steel and aluminium industries while exploring the evolving role of trade finance in safeguarding industrial resilience.
During the roundtable discussion, Ashish Chauhan, MD & CEO of the National Stock Exchange, highlighted India's opportunity to leverage its services and experience-driven sectors as engines of growth.
'Our strategy need not be reactionary. While we may work on improving goods exports with finance, technology upgradation, incentives, policies and trade deals, our services and experience-driven sectors have boundless potential and are key to shaping our global economic presence,' he noted.
Experts then turned to specific challenges while negotiating favourable terms in free-trade agreements.
Key themes included enhancing GIFT City's global competitiveness, integrating UPI into trade finance, and ensuring a balanced approach to multinational and MSME interests.
Dr. Ramanand, Director of CPRG, highlighted that the roundtable represents a crucial step in forging cross-sector synergy.
'Continuous dialogue between economists, industry and institutions is essential to navigate the complexities of the global trade landscape. Our approach should be to build consensus among all the stakeholders while also holding India's economic interests as a priority,' he emphasised.
CPRG's Trade Roundtable Series will continue with sector-specific dialogues in the coming weeks, informing India's long-term trade strategy amid an increasingly shifting geopolitical climate.
The next round of discussion will be held in Delhi on June 30, with stakeholders in the manufacturing and startup sectors. (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
an hour ago
- India.com
Indian Govt Denies Issuing Orders To Withhold Reuters Handle On X, Says Working To Resolve
As the X handle of the international news agency Reuters is currently inaccessible to Indian users, the Centre has denied any role in the same and said that there has been no requirement from the Indian Government and that work is going on with the social media platform owned by Elon Musk to resolve the issue. ANI quoted the Official Spokesperson, Ministry of Electronics and Information Technology, as saying, "There is no requirement from the Government of India to withhold the Reuters handle. We are continuously working with 'X' to resolve the problem." "There is no requirement from the Government of India to withhold the Reuters handle. We are continuously working with 'X' to resolve the problem," says the Official Spokesperson, Ministry of Electronics and Information Technology. — ANI (@ANI) July 6, 2025 This clarification by the Indian government comes after the official handle of the organisation was withheld in India. The page of Reuters on the social media platform currently shows 'Account Withheld'. "@Reuters has been withheld in IN in response to a legal demand," the page reads.
Mint
an hour ago
- Mint
Ease of doing business: Telangana govt allows 10-hr workdays for commercial establishment. Here's what changes for you…
Workers tied to commercial establishments in Telangana may have longer work weeks to look forward to, as the state government has announced a new policy permitting up to 10 hour workdays, according to an ANI report. The policy is subject to specific labour safeguards to ensure the protection of workers, and comes as Telangana aims to improve the ease of doing business, and offer greater flexibility to businesses, the report added. The new policy outlines that the total working hours for an employee must not exceed 48 hours in a week. The government has mandated that any work performed beyond the 48-hour weekly limit must be compensated with overtime wages. If an employee works for more than six hours in a single day, they are entitled to take a rest break of 30 minutes. The total work duration in a day, including overtime, must not exceed 12 hours under any circumstance. The maximum overtime is capped at 144 hours per quarter. Notably, various industrialists and CEOs in India have been advocating for increased work hours and debating over how much more work hours is needed, to much public blowback. But, there have also been some on the opposite side of the spectrum, advocating instead for work-life balance and quality of work vs quantity. Earlier this year, Mahindra Group Chairman Anand Mahindra joined in on the work hours debate, noting that quality of work is more important, than the quantity of work. On the other side, Infosys' co-founder Narayana Murthy and Larsen & Toubro Chairman SN Subrahmanyan took the brunt of public trolling and criticism for suggesting that Indians should work 70 hour and 90 hours each week, respectively. In April 2023, the Tamil Nadu Assembly also passed the Factories (Amendment) Act 2023, which extended working hours for factory workers from eight to 12-hour daily. However, the government assured that the total working hours in a week would remain unchanged for workers, and instead they would have the option to work for four days in a week and avail of three days of leave. Notably, several countries, particularly in Europe are experimenting with or have adopted a four-day workweek.
Mint
2 hours ago
- Mint
Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report
New Delhi [India], July 6 (ANI): Pharmaceutical firms are expected to post 11 per cent year-on-year growth in both sales and EBITDA for the first quarter of Financial Year 2026 (Q1FY26), driven by sustained momentum across most markets, according to a report by Kotak Institutional Equities. However, the report added that the muted domestic demand in April and March may slightly offset gains. The hospitals segment is projected to see robust 17 per cent year-on-year growth in both sales and EBITDA, supported by increased footfalls, new bed additions, and a modest rise in ARPOB. In diagnostics, volume growth, better mix, and M&A activity are expected to contribute to a 14 per cent YoY sales increase across the coverage. "For pharma companies, we expect continued traction across most markets to drive 11%/11% yoy growth in overall sales/EBITDA in 1QFY26," the report added. India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion. The domestic pharma industry is considered to be the world's third largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level. According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry i.e. Pharmaceuticals, medicinal and botanical products is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is ₹ 1,75,583 crores. As per government data 9,25,811 number of persons are engaged in Pharmaceuticals, medicinal and botanical products industry during FY 2022-23. Research & Development (R&D) and innovation in Pharma Sector is done by number of institutions and organizations under various scientific Ministries/Departments. The Department of Pharmaceuticals has set up seven National Institutes of Pharmaceutical Education & Research (NIPERs) as institutes of national importance, which besides imparting postgraduate and doctorate education, conduct high end research in various pharma specializations. Further, Department has framed a "National Policy on Research & Development and Innovation in Pharma-MedTech Sector in India" to encourage R&D in pharmaceuticals and medical devices.
